Clinical Trials Logo

Renal Insufficiency clinical trials

View clinical trials related to Renal Insufficiency.

Filter by:
  • Not yet recruiting  
  • « Prev · Page 10

NCT ID: NCT01537445 Not yet recruiting - Diabetes Clinical Trials

MR-Evaluation of Renal Function-After-Pancreas-transplantation

MERFAP
Start date: February 2012
Phase: N/A
Study type: Observational

The purpose of this study is to evaluate the beneficial effect of pancreas transplantation for long term kidney function in patients undergoing single-pancreas transplantation.

NCT ID: NCT01346215 Not yet recruiting - Clinical trials for Chronic Renal Failure

Study of Clinical Non-inferiority of Actparin® (Laboratorio Bergamo) Compared to Heparin Sodium (APP Pharmaceuticals), in Patients With Chronic Renal Failure

Start date: October 2011
Phase: Phase 3
Study type: Interventional

The purpose of this study is to investigate clinical non-inferiority, pharmacodynamic effect and safety of Actparin® (heparin sodium - Laboratório Químico Farmacêutico Bergamo Ltd.) compared to Heparin Sodium (APP Pharmaceuticals) in patients with renal failure under hemodialysis treatment.

NCT ID: NCT01157260 Not yet recruiting - Clinical trials for Kidney Failure, Chronic

The Effects of AST-120 on Endothelial Dysfunction in Patients With Chronic Kidney Disease

Start date: September 2010
Phase: Phase 4
Study type: Interventional

Indoxyl sulfate (IS) is a uremic toxin that accelerates the progression of chronic kidney disease (CKD). AST-120 (Kremezin®; Kureha Corporation, Tokyo, Japan) removes indole, which is the precursor of IS, in the intestine, and reduces the accumulation of IS. This drug has been shown to retard the deterioration of renal function in CKD patients through reducing the levels of IS. IS was reported to promote aortic calcification and stimulate the proliferation of vascular smooth muscle cells (VSMC). IS also inhibits endothelial proliferation and wound repair. With this background, the investigators will performed the study whether AST-120 improve the endothelial dysfunction in CKD patients.

NCT ID: NCT01155297 Not yet recruiting - Clinical trials for Kidney Failure, Chronic

Effect of PT on QL, FC, PWV and Biochemical Markers in CRF on Conservative Treatment

Start date: June 2010
Phase: N/A
Study type: Interventional

Introduction: Chronic Kidney Disease (CKD) is considered an important public health problem, with prevalence of 9.6% in our population. The CKD has as main symptoms fatigue, muscle weakness and poor exercise tolerance, which directly contribute to physical inactivity and low mobility, increasing the risk of morbidity and mortality in CKD patients with significant impact on quality of life of these patients. Thus, patients with CKD have poor quality of life, high incidence of cardiovascular diseases, high prevalence of endothelial dysfunction, the consequent increase in arterial stiffness and serum concentration of asymmetric dimethylarginine (ADMA). It is believed that the conditioning of these patients may reduce cardiovascular risks and improve the quality of life. Aim of the study: Evaluate the impact of exercise training in relation to functional capacity, quality of life, pulse wave velocity and ADMA in patients with CKD on dialysis. Materials and methods: Is a randomized controlled study, with 34 CKD patients on conservative treatment, divided into control group (with stretching exercises and metabolic exercises) and training group, those undergoing physical training, aerobic and resistance during six months. Before and after exercise training, patients will be assessed using the SF-36 and IPAQ. Also be held assessment of pulse wave velocity, measurement of serum ADMA and spirometry testing. Statistical analysis consisted of t test for independent data or chi-square when appropriate.

NCT ID: NCT00720967 Not yet recruiting - Clinical trials for Cardiovascular Disease

Preop Hemodialysis or Intraop Ultrafiltration for Patients With Severe Renal Dysfunction Undergoing Open Heart Surgery

SeRenaD-CPB
Start date: November 2008
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine whether preoperative hemodialysis or intraoperative modified ultrafiltration are effective for patients with non-dialysis dependent severe renal dysfunction undergoing open heart surgery.

NCT ID: NCT00716001 Not yet recruiting - Clinical trials for Chronic Renal Failure

Effect of Hydration With Sodium Bicarbonate for Long-Term Clinical Outcomes in Patients With Chronic Kidney Disease Undergoing an Emergent Coronary Procedure

Start date: July 2008
Phase: Phase 4
Study type: Interventional

This study is to evaluate the efficacy of sodium bicarbonate plus N-acetylcysteine for the prevention of contrast-induced nephropathy.

NCT ID: NCT00527059 Not yet recruiting - Heart Failure Clinical Trials

Renal Effects of Levosimendan in Patients Admitted With Acute Decompensated Heart Failure

Start date: October 2007
Phase: Phase 4
Study type: Interventional

The purpose of this study is to evaluate the effect of levosimendan infusion, in addition to standard therapy,on renal function in patients with Acute Heart Failure,compared with standard therapy alone.

NCT ID: NCT00172302 Not yet recruiting - Clinical trials for Kidney Failure, Chronic

Can Intravenous Vitamin C Improve Skin Hyperpigmentation in Long-Term Hemodialysis Patients?

Start date: November 2005
Phase: N/A
Study type: Interventional

Intravenous vitamin C may improve skin hyperpigmentation in chronic hemodialysis patients